In autoimmune diseases such as rheumatoid arthritis (RA) and multiple sclerosis (MS), Kv1.3 blockers can hamper the autoreactive T cell functions, making them a therapeutic target [15,16]. The gene discussed is KCNA3; the disease is rheumatoid arthritis.